Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Diabetes
MedTech
Embecta to buy auto-injector maker Owen Mumford for $200M
Embecta has agreed to pay 100 million pounds sterling upfront for the company, or about $134.3 million, plus 50 million pounds in sales milestones.
Conor Hale
Mar 19, 2026 4:30pm
MiniMed claims FDA clearance for small, screen-free insulin pump
Mar 19, 2026 10:40am
Insulet recalls certain Omnipod 5 pumps over insulin leaks
Mar 13, 2026 1:12pm
Sana shares 14-month data for ‘functional cure’ diabetes program
Mar 13, 2026 10:55am
Newly minted MiniMed nets CE mark for 780G pump, Instinct CGM
Mar 11, 2026 10:05am
Medtronic's diabetes business MiniMed eyes $784M IPO
Feb 24, 2026 9:35am
